NASDAQ:GEHC - Nasdaq - US36266G1076 - Common Stock - Currency: USD
74.38
-0.48 (-0.64%)
The current stock price of GEHC is 74.38 USD. In the past month the price increased by 3.98%. In the past year, price decreased by -4.54%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.11 | 233.80B | ||
ISRG | INTUITIVE SURGICAL INC | 69.86 | 191.29B | ||
BSX | BOSTON SCIENTIFIC CORP | 39.46 | 157.61B | ||
SYK | STRYKER CORP | 31.41 | 150.40B | ||
MDT | MEDTRONIC PLC | 15.64 | 110.32B | ||
BDX | BECTON DICKINSON AND CO | 12.13 | 48.97B | ||
EW | EDWARDS LIFESCIENCES CORP | 30.08 | 45.88B | ||
IDXX | IDEXX LABORATORIES INC | 46.61 | 43.06B | ||
RMD | RESMED INC | 28.1 | 37.41B | ||
DXCM | DEXCOM INC | 52.32 | 33.85B | ||
STE | STERIS PLC | 25.57 | 23.46B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 14.99 | 22.69B |
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. The company is headquartered in Chicago, Illinois and currently employs 53,000 full-time employees. The company went IPO on 2022-12-15. Its business segments include Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its AVS segment offers ultrasound, image guided therapies, and interventional solutions with a portfolio that spans the continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment develops and produces two types of imaging agents: contrast media and radiopharmaceuticals.
GE HEALTHCARE TECHNOLOGY
500 West Monroe Street
Chicago ILLINOIS US
Employees: 53000
Phone: 18337351139
The current stock price of GEHC is 74.38 USD. The price decreased by -0.64% in the last trading session.
The exchange symbol of GE HEALTHCARE TECHNOLOGY is GEHC and it is listed on the Nasdaq exchange.
GEHC stock is listed on the Nasdaq exchange.
26 analysts have analysed GEHC and the average price target is 88.82 USD. This implies a price increase of 19.41% is expected in the next year compared to the current price of 74.38. Check the GE HEALTHCARE TECHNOLOGY stock analysts ratings, price target forecast and up-and down grades for more detailed information.
GE HEALTHCARE TECHNOLOGY (GEHC) has a market capitalization of 34.06B USD. This makes GEHC a Large Cap stock.
GE HEALTHCARE TECHNOLOGY (GEHC) currently has 53000 employees.
GE HEALTHCARE TECHNOLOGY (GEHC) has a support level at 72.63 and a resistance level at 74.39. Check the full technical report for a detailed analysis of GEHC support and resistance levels.
The Revenue of GE HEALTHCARE TECHNOLOGY (GEHC) is expected to grow by 3.03% in the next year. Check the estimates tab for more information on the GEHC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
GE HEALTHCARE TECHNOLOGY (GEHC) has a dividend yield of 0.19%. The yearly dividend amount is currently 0.12. Check the full fundamental report for a detailed analysis of GEHC dividend history, reliability and sustainability.
GE HEALTHCARE TECHNOLOGY (GEHC) will report earnings on 2025-07-31, before the market open.
The PE ratio for GE HEALTHCARE TECHNOLOGY (GEHC) is 16.17. This is based on the reported non-GAAP earnings per share of 4.6 and the current share price of 74.38 USD. Check the full fundamental report for a full analysis of the valuation metrics for GEHC.
The outstanding short interest for GE HEALTHCARE TECHNOLOGY (GEHC) is 1.35% of its float. Check the ownership tab for more information on the GEHC short interest.
ChartMill assigns a technical rating of 4 / 10 to GEHC. When comparing the yearly performance of all stocks, GEHC is a bad performer in the overall market: 74.78% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to GEHC. While GEHC has a great profitability rating, there are quite some concerns on its financial health.
Over the last trailing twelve months GEHC reported a non-GAAP Earnings per Share(EPS) of 4.6. The EPS increased by 15.29% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 11.03% | ||
ROA | 6.5% | ||
ROE | 23.76% | ||
Debt/Equity | 0.74 |
ChartMill assigns a Buy % Consensus number of 81% to GEHC. The Buy consensus is the average rating of analysts ratings from 26 analysts.
For the next year, analysts expect an EPS growth of -7.65% and a revenue growth 3.03% for GEHC